Edition:
India

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

0.21USD
21 Sep 2018
Change (% chg)

$0.02 (+10.05%)
Prev Close
$0.19
Open
$0.20
Day's High
$0.22
Day's Low
$0.20
Volume
234,445
Avg. Vol
165,675
52-wk High
$1.52
52-wk Low
$0.18

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

BRIEF-Kathryn Collier Joins Regulus Board Of Directors

* KATHRYN J. COLLIER JOINS REGULUS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

18 Apr 2018

Competitors

Earnings vs. Estimates